Case Study # 1: From Low Adoption to 43% Growth

When a leading pharmaceutical company faced an unexpected challenge after launching a new treatment, they turned to Biotech & Pharma Consulting for answers—and results.

The Challenge

Despite a successful product launch, physician adoption was significantly below expectations.

“Physicians aren’t prescribing our new treatment as expected. We need help identifying why—and turning it around.” – Marketing Lead, Pharma Client

Our Diagnosis

After working closely with their Marketing, Sales, Medical Affairs, and Market Research teams, we quickly identified two major barriers:

• Lack of clear differentiation versus competitors
• Minimal endorsement from respected Opinion Leaders (OLs)

Our Solution

We designed a two-pronged strategy that would not only address the core issues but also deliver tangible commercial results:

Tailored Digital Communication Campaign

1. Custom messages targeted to segmented HCP audiences
2. Clear articulation of product benefits vs. competition
3. Enhanced engagement across digital touchpoints

KOL Activation & Peer Influence

4. Developed an Ambassador Excellence Program: a closed-door session where OLs aligned around key brand messages
5. Followed by an Expert Summit where those OLs educated high-prescribing peers on the product's value proposition

The Results

✅ Message Clarity Improved – Key differentiation messages increased brand clarity by 37%. Physicians gained a stronger understanding of the product’s unique value within 12 months.

✅ Stronger Brand Advocacy – KOL alignment reinforced consistent brand messaging and amplified peer-to-peer influence across key markets.

✅ Significant Market Growth – Prescription volume and market share rose by 43% year-over-year in the second year post-launch.